- Gatsbie
- Investor lists
- AI
- AI and Biotech
AI and Biotech investors
230 funds · Updated
Gatsbie lists 230 AI and Biotech investors (as of 2026-11-18).
Each one names both artificial intelligence and biotech & life sciences in its investment focus.
Most are based in United States (129), United Kingdom (24) and Germany (8); the most common stages are Seed (201), Series A (189) and Pre-Seed (159); the most common kinds of capital are Venture equity (216), Growth equity (60) and Buyout (20).
Which investors back AI and Biotech startups?
Gatsbie lists 230 AI and Biotech investors (as of 2026-11-18). Most are in United States (129), United Kingdom (24) and Germany (8). They include Amoon Fund (Ra'anana), Development Partners International (London), Redalpine Venture Partners AG (Zürich), Ideaspring Capital (Bengaluru), Andreessen Horowitz (Menlo Park) and DCVC (San Francisco). Most deals on record in the last 24 months: Amoon Fund (7 deals), Development Partners International (3 deals) and Redalpine Venture Partners AG (1 deal).
Which family offices invest in AI and Biotech?
14 of the 230 AI and Biotech investors on Gatsbie are family offices, including AUREC CAPITAL, INTERGROUP PARTNERS AG, BROADVIEW VENTURES, ERAGON FAMILY OFFICE and RUSHWORTH INVESTMENTS.
Upload your deck to see which of these fit your startup, with a written reason for each.
20 of 230 funds
Most active first: deals in the last 24 months, then portfolio companies on record.
| # | Fund | HQ | Stages | Partner emails |
|---|---|---|---|---|
| 1 | Amoon Fund | Ra'anana | Seed–Series C+ | 15 |
| 2 | Development Partners International | London | Seed–Series C+ | 10 |
| 3 | Redalpine Venture Partners AG | Zürich | Pre-Seed–Series A, Series C+ | 12 |
| 4 | Ideaspring Capital | Bengaluru | Pre-Seed–Series B | 7 |
| 5 | Andreessen Horowitz | Menlo Park | Seed–Series C+ | 38 |
| 6 | DCVC | San Francisco | Pre-Seed–Series B | 11 |
| 7 | HOF Capital | New York | Pre-Seed–Series B | 16 |
| 8 | 8VC | San Francisco | Seed–Series C+ | 19 |
| 9 | F-Prime Capital | Cambridge | Pre-Seed–Series B | 32 |
| 10 | Innovation Endeavors | Palo Alto | Pre-Seed–Series B | 9 |
| 11 | Amplify Partners | Menlo Park | Pre-Seed–Series A, Growth | 12 |
| 12 | Air Street Capital | London | Pre-Seed–Series B | 1 |
| 13 | BlueYard | Berlin | Pre-Seed–Series A, Series C+ | 12 |
| 14 | General Catalyst | Prague | Pre-Seed–Series B | 10 |
| 15 | Avalon Ventures | La Jolla | Pre-Seed–Series B | 6 |
| 16 | Eight Roads Ventures | London | Seed–Series C+ | 11 |
| 17 | Metavallon Venture Capital | – | Pre-Seed, Seed | 8 |
| 18 | TenOneTen Ventures | Los Angeles | Pre-Seed–Series B | 7 |
| 19 | True Ventures | Palo Alto | Pre-Seed, Seed | 13 |
| 20 | BOLD Capital Partners | Santa Monica | Pre-Seed–Series A, Growth | 8 |
Other sector pairs
AI and Biotech investors elsewhere
AI investors by school
- Harvard University 763
- Stanford University 634
- University of Pennsylvania 519
- Columbia University 376
- University of California, Berkeley 335
- Massachusetts Institute of Technology (MIT) 291
- University of Oxford 244
- Northwestern University 234
- New York University 218
- University of Chicago 218
- London School of Economics (LSE) 213
- Yale University 206
- INSEAD 203
- Cornell University 183
- University of Michigan 180
- Duke University 178
Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Only funds naming both sectors are listed.
